Dose Optimization and Reduction in CT of the Head and Neck, Including Brain

Author(s):  
Tom Mulkens ◽  
Rodrigo Salgado ◽  
Patrick Bellinck
1990 ◽  
Vol 19 (4) ◽  
pp. 307-316 ◽  
Author(s):  
T.W. Griffin ◽  
K.L. Martz ◽  
G.E. Laramore ◽  
F.J. Thomas ◽  
M.H. Maor ◽  
...  

2010 ◽  
Vol 129 (4) ◽  
pp. 870-878 ◽  
Author(s):  
Bianca A.W. Hoeben ◽  
Janneke D.M. Molkenboer-Kuenen ◽  
Wim J.G. Oyen ◽  
Wenny J.M. Peeters ◽  
Johannes H.A.M. Kaanders ◽  
...  

Open Physics ◽  
2021 ◽  
Vol 19 (1) ◽  
pp. 146-151
Author(s):  
Chuou Yin ◽  
Peng Yang ◽  
Shengyuan Zhang ◽  
Shaoxian Gu ◽  
Ningyu Wang ◽  
...  

Abstract Purpose The aim of this study is to investigate an implementation method and the results of a voxel-based self-adaptive prescription dose optimization algorithm for intensity-modulated radiotherapy. Materials and methods The self-adaptive prescription dose optimization algorithm used a quadratic objective function, and the optimization engine was implemented using the molecular dynamics. In the iterative optimization process, the optimization prescription dose changed with the relationship between the initial prescription dose and the calculated dose. If the calculated dose satisfied the initial prescription dose, the optimization prescription dose was equal to the calculated dose; otherwise, the optimization prescription dose was equal to the initial prescription dose. We assessed the performance of the self-adaptive prescription dose optimization algorithm with two cases: a mock head and neck case and a breast case. Isodose lines, dose–volume histogram, and dosimetric parameters were compared between the conventional molecular dynamics optimization algorithm and the self-adaptive prescription dose optimization algorithm. Results The self-adaptive prescription dose optimization algorithm produces the different optimization results compared with the conventional molecular dynamics optimization algorithm. For the mock head and neck case, the planning target volume (PTV) dose uniformity improves, and the dose to organs at risk is reduced, ranging from 1 to 4%. For the breast case, the use of self-adaptive prescription dose optimization algorithm also leads to improvements in the dose distribution, with the dose to organs at risk almost unchanged. Conclusion The self-adaptive prescription dose optimization algorithm can generate an ideal clinical plan more effectively, and it could be integrated into a treatment planning system after more cases are studied.


Sign in / Sign up

Export Citation Format

Share Document